Open access · OA
via Europe PMC
A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives.
Mahbub TB, Safaeian P, Sohrabi S.
Frontiers in aging · 2026
Abstract
Aging is driven by interconnected genetic, epigenetic, molecular, and physiological processes spanning from unicellular to organismal levels. The surge in high-throughput data, from clinical and imaging to multi-omics, has outpaced traditional analysis methods; driving the integration of artificial intelligence (AI) into aging research. This comprehensive review examines the application of machine learning, deep learning, and computer vision across four canonical aging models (yeast, <i>Caenorhabditis elegans</i>, <i>Drosophila melanogaster</i>, and mice), highlighting AI's role in lifespan prediction, biomarker and gene discovery, aging-clock construction, and assay automation via automated animal counting and imaging. However, only 3% of the reviewed studies incorporated <i>in vivo</i> biological validation with common issues including small and imbalanced datasets, dataset bias, prediction noise, lack of cross-species analyses, absence of cytotoxicity testing, and overreliance on synthetic data. These drawbacks pose AI as just an aiding tool rather than a standalone solution, and without improvements in these sectors, AI-derived findings should be considered hypothesis generating rather than definitive conclusions. To address these issues, we propose the development of a standardized scoring system, AI Quality Assessment Metric (AI-QAM), for aging research that will evaluate studies on six criteria: (1) dataset size, (2) feature dimensionality, (3) biological validation type, (4) species diversity, (5) model generalizability, and (6) interpretability. Moreover, to mitigate the problem of lacking a unifying of a framework integrating AI approaches with biological mechanisms of aging, we present a conceptual framework, mapping AI applications across biological levels and aging hallmarks. AI will fulfill its potential in aging research only when it is firmly grounded in biological principles, systematically benchmarked, and rigorously validated through experimental studies.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fragi.2026.1644669
- Canonical
- link ↗
- Fetched
- 2026-05-31 MST
Cite this
APA
TB, M., P, S., & S., S. (2026). A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives. <em>Frontiers in aging</em>. https://doi.org/10.3389/fragi.2026.1644669
Vancouver
TB M, P S, S. S. A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives. Frontiers in aging. 2026. doi:10.3389/fragi.2026.1644669.
BibTeX
@article{mahbub2026Acompr,
title = {A comprehensive review of artificial intelligence as a catalyst in aging research: insights, gaps and future perspectives.},
author = {Mahbub TB and Safaeian P and Sohrabi S.},
journal = {Frontiers in aging},
year = {2026},
doi = {10.3389/fragi.2026.1644669},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in aging 2025
Open access · OA
Toward precision longevity: aging interventions in the single-cell atlas era.
Frontiers in aging 2025
Open access · OA
Biomarker integration and biosensor technologies enabling AI-driven insights into biological aging.
Journal of cosmetic dermatology 2026
Open access · OA
Translating Geroscience Into Clinical Longevity Dermatology: From Mechanisms of Aging to Skin-Centered Interventions.
PubMed 2024
Preprint · CC-BY
Ischemic Stroke and the Biological Hallmarks of Aging.
Aging and Disease 2024
Open access · CC-BY
Ischemic Stroke and the Biological Hallmarks of Aging
Current Opinion in Epidemiology and Public Health 2023
Open access · CC-BY